Male patients with TERT mutation may be more likely to benefit from immunotherapy, especially for melanoma.

Li, Jia; Li, Zhaoyan; Zhang, Chenyue; Zhang, Chenxing; Wang, Haiyong

Li, Jia; Li, Zhaoyan; Zhang, Chenyue; Zhang, Chenxing; Wang, Haiyong.

Afiliação

Li J; Department of Integrated Chinese and Western Medicine, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450008, China.
Li Z; Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine (TCM), Shanghai 200437, China.
Zhang C; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai 00032, China.
Zhang C; Department of Nephrology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Wang H; Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.

Aging (Albany NY) ; 12(17): 17288-17294, 2020 Sep 10.

Article em En | MEDLINE | ID: mdl-32915164

Palavras-chave

TERT mutation; immunotherapy; melanoma; sex disparity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Aging (Albany NY) Assunto da revista: GERIATRIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google